Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Aronex regains worldwide marketing rights to Atragen

April 1, 1999

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

April 1, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

New microbially produced inhibitor of HSP expression in development at Mercian

April 1, 1999

O6-Benzylguanine shows potential for oral efficacy in humans

March 31, 1999

Studies on BTK inhibitors expected to result in discovery of new anticancer drugs

March 31, 1999

Results of Onconase trial in malignant mesothelioma reported

March 31, 1999

ACS highlights: Dainippon selects potent antitumor compound for development

March 30, 1999

New antileukemia agents synthesized at Hughes Institute

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...